How are Developments in PCR Diagnostics Helping Cancer Patients

Pharma Tech Outlook: Pharma Tech Magazine

How are Developments in PCR Diagnostics Helping Cancer Patients

By Pharma Tech Outlook | Friday, September 11, 2020

The technological advancement in the PCR Diagnostics is changing the treatment procedures for cancer patients and helping doctors heal them rapidly.

FREMONT, CA: The field of molecular biology has advanced, and its demand has increased rapidly because of the polymerase chain reaction (PCR). PCR is an essential technology that is used for detecting and analyzing nucleic acids. Since PCR was introduced in the medical sector, it has become a go-to process for strengthening specific sequences of the DNA and in some cases, RNA also for many purposes. Generally, PCR is the core of several genomic applications, and it might be DNA fingerprinting, studying generic disorder, gene-mapping, or detecting bacterial/viral infections.

The molecular biologists are more attracted to PCR because of its specificity and sensitivity. The maximum of the quantitative, real-time PCR examination available today are more sensitive and also more specific than the plate-based immunoassays.

The techniques of digital PCR are also useful while detecting variations like point mutations and copy number variants. Furthermore, PCR has also shown high reproducibility across several laboratories without calibration.

Check out: Top Oncology Solution Companies

The PCR has become the perfect standard of analyzing gene expression due to its capability to detect almost everything starting from cancer to microbial infections, and even fungal infections. PCR can also be used as a diagnostic strategy while categorizing not only vital yeast species but also for identifying mutations that can guide the therapeutic decisions for lung cancer patients.Top Drug Discovery and Development Solution Companies

PCR-Powered Liquid Biopsy Can Guide Cancer Therapy

Wait time in cancer treatment can make a huge difference. The wait time for the liquid biopsy is shorter than the tissue biopsy. It will take less time to make treatment decisions with the decrease of wait time and can start the process of healing at an early stage. The biomarker data available in the first stage of the treatment can facilitate the oncologists to review cases more effectively and deliver the best options of treatment. 

A Multiplex PCR Analyzation for Identifying Yeast Species

Another well-established analysis method in medical microbiology is the real-time PCR. This type of PCR is specially used for viral and bacterial infections, but it is still at the research level.

However, the research world of the healthcare sector might presently witness a shift in the epidemiology of infectious yeast species, but the application of the real-time PCR is still at its nascent stage.

See also: Top Pharma and Life Sciences Tech Solution Companies

Weekly Brief

Read Also